Physician profile
Brian Johnson
NPI 1952782021
$2,255.94
in general payments reported to CMS, 2019-2025
19 companies · $338 in 2025
The $338 reported for 2025 was less than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,054 · 2020: $110 · 2022: $188 · 2023: $136 · 2024: $430 · 2025: $338.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $839 · Education: $64.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $838.63 |
| Education | $64.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seagen INC. | $345.01 | 2019-2023 | Tukysa |
| Histosonics, INC. | $316.92 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $295.15 | 2022-2025 | Opdivo |
| Incyte Corporation | $223.98 | 2019 | |
| Astellas Pharma US INC | $194.99 | 2019 | |
| Merck Sharp & Dohme LLC | $130.45 | 2019-2025 | Keytruda, Keytruda Qlex |
| Genentech USA, INC. | $129.17 | 2019 | |
| Alexion Pharmaceuticals, INC. | $89.95 | 2019 | |
| Amgen INC. | $83.31 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $75.99 | 2019 | |
| Sirtex Medical INC | $75.73 | 2022 | |
| Pharmacyclics LLC, An Abbvie Company | $71.99 | 2019 | |
| Tempus Ai, INC | $55.98 | 2024-2025 | Xt Cdx |
| Astrazeneca Pharmaceuticals Lp | $37.43 | 2022-2024 | |
| Caris Mpi, INC. | $32.42 | 2025 | Mi Cancer Seek |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $28.26 | 2025 | |
| Myriad Genetic Laboratories, INC. | $27.49 | 2024 | Myrisk |
| Pfizer INC. | $26.55 | 2024 | |
| Astellas Pharma Global Development | $15.17 | 2025 | Vyloy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.